Huang Qing, Li Benpeng, Yang Shuo, Ma Peipei, Wang Zhizhong
School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia 750004, China.
ScientificWorldJournal. 2013 Jul 21;2013:306476. doi: 10.1155/2013/306476. eCollection 2013.
A one-pot method for the preparation of benzoyl metronidazole was achieved by using N,N'-carbonyldiimidazole as a coupling reagent. Moreover, it was found that the byproduct imidazole as the catalyst promoted the reaction. In addition, the β-cyclodextrin solubilization of benzoyl metronidazole was investigated by phase-solubility method. The phase-solubility studies indicated that the solubility of benzoyl metronidazole (S = 0.1435 g/L) was substantially increased 9.7-fold (S' = 1.3881 g/L) by formation of 1 : 1 benzoyl metronidazole/β-cyclodextrin complexes in water, and the association constant K(a) value was determined to be 251 (±23) dm(3)/mol. Therefore, β-cyclodextrin can work as a pharmaceutical solubilizer for benzoyl metronidazole and may improve its oral bioavailability.
通过使用N,N'-羰基二咪唑作为偶联试剂,实现了一种制备苯甲酰甲硝唑的一锅法。此外,发现副产物咪唑作为催化剂促进了该反应。另外,采用相溶解度法研究了β-环糊精对苯甲酰甲硝唑的增溶作用。相溶解度研究表明,在水中形成1:1的苯甲酰甲硝唑/β-环糊精复合物后,苯甲酰甲硝唑的溶解度(S = 0.1435 g/L)大幅提高了9.7倍(S' = 1.3881 g/L),缔合常数K(a)值测定为251(±23)dm³/mol。因此,β-环糊精可作为苯甲酰甲硝唑的药物增溶剂,并可能提高其口服生物利用度。